Chloe Goldsmith is an immune-genomics researcher whose work focuses on understanding how epigenetic mechanisms regulate immune cell identity, function, and plasticity in health and disease. Her research investigates how dynamic epigenetic modifications shape immune responses and contribute to immune dysfunction across a range of conditions, including infectious diseases, autoimmune disorders, and cancer. By integrating genomics, epigenetics, and immunology, Chloe aims to elucidate the molecular pathways that govern immune cell behaviour and identify biomarkers and therapeutic targets that can be translated into improved diagnostics and precision medicine approaches.